NCT02641145View on ClinicalTrials.gov

Molecular Imaging of Primary Amyloid Cardiomyopathy

NARecruitingINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

January 8, 2025

Study Completion Date

January 8, 2025

Conditions
Amyloidosis, PrimaryCardiomyopathy
Interventions
RADIATION

F-18 florbetapir/C-11 acetate PET

F-18 florbetapir PET scan, C-11 acetate PET scan

DEVICE

MRI

Cardiac MRI with gadolinium contrast.

RADIATION

N-13 ammonia PET

N-13 ammonia PET scan following supine bicycle stress.

Trial Locations (1)

02421

RECRUITING

Brigham and Womens' Hospital, Boston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

American Heart Association

OTHER

lead

Brigham and Women's Hospital

OTHER